These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33791919)

  • 1. LncRNA TUG1 exhibits pro-fibrosis activity in hypertrophic scar through TAK1/YAP/TAZ pathway via miR-27b-3p.
    Li XM; Yu WY; Chen Q; Zhuang HR; Gao SY; Zhao TL
    Mol Cell Biochem; 2021 Aug; 476(8):3009-3020. PubMed ID: 33791919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of long noncoding INHBA antisense RNA1 suppresses proliferation, migration, and extracellular matrix deposition in human hypertrophic scar fibroblasts via regulating microRNA-141-3p/myeloid cell leukemia 1 axis.
    Yang Y; Xiao C; Liu K; Song L; Zhang Y; Dong B
    Bioengineered; 2021 Dec; 12(1):1663-1675. PubMed ID: 33977869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA H19 promotes the proliferation, migration and invasion while inhibits apoptosis of hypertrophic scarring fibroblasts by targeting miR-3187-3p/GAB1 axis.
    Xiao M; Zou X; Li B; Zhang B
    Burns; 2021 May; 47(3):654-664. PubMed ID: 32888745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
    Tang Y; Yang P; Zhu Y; Su Y
    Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-3613-3p inhibits hypertrophic scar formation by down-regulating arginine and glutamate-rich 1.
    Li L; Han W; Chen Y; Chen Y
    Mol Cell Biochem; 2021 Feb; 476(2):1025-1036. PubMed ID: 33165823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of the lncRNA
    Zhang B; Zhao C; Hou L; Wu Y
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MIR503HG promotes hypertrophic scar progression via miR-143-3p-mediated Smad3 expression.
    Wei J; Wang Z; Zhong C; Ding H; Wang X; Lu S
    Wound Repair Regen; 2021 Sep; 29(5):792-800. PubMed ID: 33819360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway.
    Xu K; Zhang L
    Dig Dis Sci; 2020 Jun; 65(6):1748-1760. PubMed ID: 31655908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
    Liu Z; Guo N; Zhang XJ
    Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA-221-3p/KIT axis.
    Zhang X; Yang L; Xu G
    Clin Hemorheol Microcirc; 2020; 76(3):425-437. PubMed ID: 32804119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
    Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
    Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA (lncRNA) nuclear enriched abundant transcript 1 (NEAT1) regulates fibroblast growth factor receptor substrate 2 (FRS2) by targeting microRNA (miR)-29-3p in hypertrophic scar fibroblasts.
    Wu Q; Chen J; Tan Z; Wang D; Zhou J; Li D; Cen Y
    Bioengineered; 2021 Dec; 12(1):5210-5219. PubMed ID: 34414852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
    Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.
    Mu S; Kang B; Zeng W; Sun Y; Yang F
    Mol Cell Biochem; 2016 May; 416(1-2):99-108. PubMed ID: 27075467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy.
    Su Q; Liu Y; Lv XW; Ye ZL; Sun YH; Kong BH; Qin ZB
    J Mol Cell Cardiol; 2019 Aug; 133():12-25. PubMed ID: 31145943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis.
    Zhang B; Sun YF; Zhang XM; Jiang N; Chen Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4940-4953. PubMed ID: 32432757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis.
    Su Q; Liu Y; Lv XW; Dai RX; Yang XH; Kong BH
    Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H332-H344. PubMed ID: 31858814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.